Trial Profile
Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Adefovir; Entecavir
- Indications Hepatitis B
- Focus Pharmacodynamics
- 04 Mar 2013 New trial record